Atossa Therapeutics Statistics
Total Valuation
ATOS has a market cap or net worth of $37.89 million. The enterprise value is -$14.47 million.
Important Dates
The next estimated earnings date is Tuesday, March 24, 2026, before market open.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATOS has 8.61 million shares outstanding. The number of shares has increased by 2.39% in one year.
| Current Share Class | 8.61M |
| Shares Outstanding | 8.61M |
| Shares Change (YoY) | +2.39% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 20.92% |
| Float | 8.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.77
| Current Ratio | 6.77 |
| Quick Ratio | 6.30 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.89% and return on invested capital (ROIC) is -33.26%.
| Return on Equity (ROE) | -48.89% |
| Return on Assets (ROA) | -29.87% |
| Return on Invested Capital (ROIC) | -33.26% |
| Return on Capital Employed (ROCE) | -65.99% |
| Weighted Average Cost of Capital (WACC) | 11.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.01M |
| Employee Count | 15 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.39% in the last 52 weeks. The beta is 1.34, so ATOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | -65.39% |
| 50-Day Moving Average | 8.74 |
| 200-Day Moving Average | 11.77 |
| Relative Strength Index (RSI) | 24.92 |
| Average Volume (20 Days) | 211,446 |
Short Selling Information
The latest short interest is 4.70 million, so 54.54% of the outstanding shares have been sold short.
| Short Interest | 4.70M |
| Short Previous Month | 3.62M |
| Short % of Shares Out | 54.54% |
| Short % of Float | 54.57% |
| Short Ratio (days to cover) | 2.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -32.86M |
| Pretax Income | -30.18M |
| Net Income | -30.18M |
| EBITDA | -32.84M |
| EBIT | -32.86M |
| Earnings Per Share (EPS) | -$3.52 |
Full Income Statement Balance Sheet
The company has $51.85 million in cash and n/a in debt, with a net cash position of $51.85 million or $6.02 per share.
| Cash & Cash Equivalents | 51.85M |
| Total Debt | n/a |
| Net Cash | 51.85M |
| Net Cash Per Share | $6.02 |
| Equity (Book Value) | 49.79M |
| Book Value Per Share | 5.78 |
| Working Capital | 47.45M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$26.27 million and capital expenditures -$16,000, giving a free cash flow of -$26.29 million.
| Operating Cash Flow | -26.27M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -26.29M |
| FCF Per Share | -$3.05 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.39% |
| Shareholder Yield | -2.39% |
| Earnings Yield | -80.75% |
| FCF Yield | -70.34% |
Analyst Forecast
The average price target for ATOS is $31.67, which is 619.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.67 |
| Price Target Difference | 619.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |